These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35892859)

  • 41. miR-148a-3p Suppresses the Proliferation and Invasion of Esophageal Cancer by Targeting DNMT1.
    Wang Y; Hu Y; Guo J; Wang L
    Genet Test Mol Biomarkers; 2019 Feb; 23(2):98-104. PubMed ID: 30735457
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-137 acts as a tumor suppressor in osteosarcoma by targeting enhancer of zeste homolog 2.
    Feng Q; Wu Q; Liu X; Xiong Y; Li H
    Exp Ther Med; 2017 Jun; 13(6):3167-3174. PubMed ID: 28587390
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ATPase copper transporter A, negatively regulated by miR-148a-3p, contributes to cisplatin resistance in breast cancer cells.
    Yu Z; Cao W; Ren Y; Zhang Q; Liu J
    Clin Transl Med; 2020 Jan; 10(1):57-73. PubMed ID: 32508020
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer.
    Zheng B; Liang L; Wang C; Huang S; Cao X; Zha R; Liu L; Jia D; Tian Q; Wu J; Ye Y; Wang Q; Long Z; Zhou Y; Du C; He X; Shi Y
    Clin Cancer Res; 2011 Dec; 17(24):7574-83. PubMed ID: 21994419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-148a suppresses invasion and induces apoptosis of breast cancer cells by regulating USP4 and BIM expression.
    Zhang L; Xing M; Wang X; Cao W; Wang H
    Int J Clin Exp Pathol; 2017; 10(8):8361-8368. PubMed ID: 31966687
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382.
    Zhao L; Sun H; Kong H; Chen Z; Chen B; Zhou M
    Cell Physiol Biochem; 2017; 42(6):2145-2158. PubMed ID: 28813705
    [TBL] [Abstract][Full Text] [Related]  

  • 47. miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer.
    Wang X; Liang Z; Xu X; Li J; Zhu Y; Meng S; Li S; Wang S; Xie B; Ji A; Liu B; Zheng X; Xie L
    Cell Death Dis; 2016 Dec; 7(12):e2503. PubMed ID: 27906180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Up-regulation of miR-299 suppressed the invasion and migration of HTR-8/SVneo trophoblast cells partly via targeting HDAC2 in pre-eclampsia.
    Gao Y; She R; Wang Q; Li Y; Zhang H
    Biomed Pharmacother; 2018 Jan; 97():1222-1228. PubMed ID: 29145147
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miR-148a suppresses cell invasion and migration in gastric cancer by targeting DNA methyltransferase 1.
    Shi H; Chen X; Jiang H; Wang X; Yu H; Sun P; Sui X
    Oncol Lett; 2018 Apr; 15(4):4944-4950. PubMed ID: 29541249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. EZH2 promotes the expression of LPA1 by mediating microRNA-139 promoter methylation to accelerate the development of ovarian cancer.
    Wu D; Wu F; Li B; Huang W; Wang D
    Cancer Cell Int; 2020 Nov; 20(1):551. PubMed ID: 33292225
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.
    Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R
    Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epigenetic network of EZH2/SFRP1/Wnt in the epithelial-mesenchymal transition of laryngeal carcinoma cells.
    Chen W; Wang HT; Ji JF; Wang ZY; Shi T; Wu MH; Yu PJ
    Neoplasma; 2022 May; 69(3):680-690. PubMed ID: 35400167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2.
    Zhang R; Li M; Zang W; Chen X; Wang Y; Li P; Du Y; Zhao G; Li L
    Tumour Biol; 2014 Jan; 35(1):837-44. PubMed ID: 23975374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-148a promotes apoptosis and suppresses growth of breast cancer cells by targeting B-cell lymphoma 2.
    Li Q; Ren P; Shi P; Chen Y; Xiang F; Zhang L; Wang J; Lv Q; Xie M
    Anticancer Drugs; 2017 Jul; 28(6):588-595. PubMed ID: 28430743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. miR-375 Inhibits the Proliferation and Invasion of Nasopharyngeal Carcinoma Cells by Suppressing PDK1.
    Jia-Yuan X; Wei S; Fang-Fang L; Zhi-Jian D; Long-He C; Sen L
    Biomed Res Int; 2020; 2020():9704245. PubMed ID: 32280708
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hsa_circ_0046523 Mediates an Immunosuppressive Tumor Microenvironment by Regulating MiR-148a-3p/PD-L1 Axis in Pancreatic Cancer.
    Fu X; Sun G; Tu S; Fang K; Xiong Y; Tu Y; Zha M; Xiao T; Xiao W
    Front Oncol; 2022; 12():877376. PubMed ID: 35712476
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA-638 induces apoptosis and autophagy in human liver cancer cells by targeting enhancer of zeste homolog 2 (EZH2).
    Zhang H; Liang H; Wu S; Zhang Y; Yu Z
    Environ Toxicol Pharmacol; 2021 Feb; 82():103559. PubMed ID: 33290872
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis.
    Chen S; Pu J; Bai J; Yin Y; Wu K; Wang J; Shuai X; Gao J; Tao K; Wang G; Li H
    J Exp Clin Cancer Res; 2018 Jan; 37(1):3. PubMed ID: 29316949
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-144 Suppresses Prostate Cancer Growth and Metastasis by Targeting EZH2.
    Sun XB; Chen YW; Yao QS; Chen XH; He M; Chen CB; Yang Y; Gong XX; Huang L
    Technol Cancer Res Treat; 2021; 20():1533033821989817. PubMed ID: 33550923
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BRCA1 positively regulates FOXO3 expression by restricting FOXO3 gene methylation and epigenetic silencing through targeting EZH2 in breast cancer.
    Gong C; Yao S; Gomes AR; Man EP; Lee HJ; Gong G; Chang S; Kim SB; Fujino K; Kim SW; Park SK; Lee JW; Lee MH; ; Khoo US; Lam EW
    Oncogenesis; 2016 Apr; 5(4):e214. PubMed ID: 27043660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.